Dinh:Thesis Overview: Difference between revisions
Jump to navigation
Jump to search
>Dinh mNo edit summary |
>Dinh mNo edit summary |
||
Line 1: | Line 1: | ||
=Thesis Project Overview= | =Thesis Project Overview= | ||
== Work flow charts == | |||
* Sample sets codes are explained below. | * Sample sets codes are explained below. | ||
==Samples: Data analysis (A) == | ==Samples: Data analysis (A) == | ||
* Sample set codes starting with A. | * Sample set codes starting with A. |
Revision as of 17:46, 13 March 2015
Thesis Project Overview
Work flow charts
- Sample sets codes are explained below.
Samples: Data analysis (A)
- Sample set codes starting with A.
A-Salk. Salk's Human Tissues Whole Genome Bisulfite Sequencing
- Paper: Not out yet
A-BGI. Human peripheral mononuclear cells trio - type 2 diabetes - father, mother, daughter
A-WB. Human whole blood DNA methylation study - newborn, middle-age, centarian
Samples: Data generation (G)
- Sample set codes starting with G.
G-SS. Early definitive endoderm differentiation (Song's 3-days protocol and Sergio's H1 samples)
Tube ID | Sample | Concentration (QUBIT, ng/ul) |
MA-16 | H1 p54 Control TeSR | 57.0 |
MA-17 | H1 p54 Activin-A | 40.1 |
AP-13 | H1 p47 Control TeSR | 85.0 |
AP-14 | H1 p47 BMP-4 | 49.4 |
ESCd0.1 | Day 0 ESCs | 40.3 |
ESCd0.2 | Day 0 ESCs | 56.0 |
ESCd0.3 | Day 0 ESCs | 86.0 |
DE-d3.1 | Day 3 definitive endoderm | 34.0 |
DE-d3.2 | Day 3 definitive endoderm | 37.7 |
DE-d3.3 | Day 3 definitive endoderm | 25.7 |
NaiveESC.1 | naïve ESCs cells | 26.3 |
NaiveESC.2 | naïve ESCs cells | 30.0 |